cons of glp 1 drugs Variable weight-loss and cardiovascular benefits were seen with GLP-1 in a systematic review and network meta-analysis, but effects on quality life were less clear. https://www.medpagetoday.com/primarycare/obesity/122142 Weight-Loss Medication Side Effects and

Results We revealed that intracellular BPC157 engages the E3 ubiquitin ligase adaptor protein FBXO22 through its proline residue at position 3

Efficacy of oral compared with intramuscular vitamin B-12 supplementation after Roux-en-Y gastric bypass: a randomized controlled trial

Biochem Biophys Res Commun (2014) 445(1):2305

In the OASIS-1 study, 13% of participants (people with obesity without diabetes) receiving oral semaglutide 50 mg experienced altered skin sensation events compared to 1% with placebo - these events were generally mild to moderate in severity, occurred during dose escalation to the higher doses and resolved without requiring permanent treatment discontinuation [21]